RESUMO

This work describes the development and validation of an ultra-high performance liquid chromatography tandem mass spectrometry method that uses disposable pipette extraction (DPX-UHPLC-MS/MS) to determine the endocannabinoid anandamide (AEA) in cerebrospinal fluid samples (CSF). The DPX parameters sorption equilibrium time, sample volume, number of draw-eject cycles, washing solvent volume, and elution solvent volume were optimized by design of experiments (DOE) techniques. The simple DPX protocol proposed herein required a reduced amount of CSF sample and organic solvent. The DPX-UHPLC-MS/MS method presented linear range from 0.10 ng mL-1 (LLOQ) to 3.0 ng mL-1, inter- and intra-assay accuracy with EPR values varying from -8.2% to 9.6%, inter- and intra-assay precision with CV values ranging from 1.3% to 14.8% (except for the LLOQ), and no significant matrix effect. The innovative DPX-UHPLC-MS/MS method was successfully applied to determine AEA in CSF samples from Parkinson's disease (PD) patients and should therefore be used in clinical studies.

Assuntos

Ácidos Araquidônicos/líquido cefalorraquidiano , Cromatografia Líquida de Alta Pressão/métodos , Endocanabinoides/líquido cefalorraquidiano , Alcamidas Poli-Insaturadas/líquido cefalorraquidiano , Espectrometria de Massas em Tandem/métodos , Ácidos Araquidônicos/isolamento & purificação , Endocanabinoides/isolamento & purificação , Humanos , Modelos Lineares , Alcamidas Poli-Insaturadas/isolamento & purificação , Reprodutibilidade dos Testes , Sensibilidade e Especificidade